Home > Riviste > Minerva Pediatrics > Fascicoli precedenti > Minerva Pediatrics 2021 December;73(6) > Minerva Pediatrics 2021 December;73(6):504-22

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

REVIEW  UPDATE IN PEDIATRIC DIABETES AND ENDOCRINOLOGY: PROCEEDING OF THE 7TH WINTER AND SUMMER ISPED SCHOOL FOR PHYSICIANS 

Minerva Pediatrics 2021 December;73(6):504-22

DOI: 10.23736/S2724-5276.21.06545-9

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Long-term complications of type 1 diabetes: what do we know and what do we need to understand?

Claudia PIONA 1, Claudia VENTRICI 2, Loredana MARCOVECCHIO 3, Francesco CHIARELLI 4, Claudio MAFFEIS 1, Riccardo BONFANTI 5, Ivana RABBONE 6

1 Pediatric Diabetes and Metabolic Disorders Unit, Regional Center for Pediatric Diabetes, University City Hospital, Verona, Italy; 2 Pediatric Unit, Hospital of Polistena, Reggio Calabria, Italy; 3 Department of Pediatrics, University of Cambridge, Cambridge, UK; 4 Department of Pediatrics, University of Chieti, Chieti, Italy; 5 Diabetes Research Institute, Department of Pediatrics, IRCCS San Raffaele Scientific Institute, Milan, Italy; 6 Division of Pediatrics, Department of Health Sciences, University of Eastern Piedmont, Novara, Italy



Long-term complications of type 1 diabetes (T1D) include microvascular complications and macrovascular disease. Despite the important advances in the treatment of T1D of the last decades, these complications still represent the leading cause of morbidity and mortality in patients with T1D. Extensive evidence indicates that structural and functional alterations of the kidney, retina, nerves and large arteries occur already in the first years after the onset of diabetes. We performed a comprehensive review of the available evidence on screening, diagnosis, prevention and treatment of vascular complications of T1D. In particular, we focused on three major challenges related to long-term complications of T1D: 1) finding of new biomarkers and diagnostic methods able to identify early signs of complications; 2) identifying specific risk factors for the development of these complications; 3) identifying and implementing new therapeutic strategies able to prevent the development and progression of vascular complications.


KEY WORDS: Type 1 diabetes mellitus; Diabetic complications; Diagnosis; Risk factors; Biomarkers; Therapeutics

inizio pagina